| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 甘李药业股份有限公司成立于1998年，是一家集科研、开发、生产、销售于一体的高科技生物制药企业。总部位于北京通州经济开发区南区，隶属于中关村国家自主创新示范区，拥有约20万平方米的产业园，公司员工近2500余名。作为中国第一家掌握产业化生产重组胰岛素类似物技术的公司，甘李在生产研发的生物合成人胰岛素及其类似物方面处于中国糖尿病市场的领先地位。在全球与Sandoz等知名企业建立密切合作。如今，作为专注人类健康事业的全球性企业，甘李秉承科学、极致的企业文化，致力于为世界范围内的糖尿病病人提供优质的产品和服务。 | ||||||||||||||||||||||||
| Main Business | 重组胰岛素类似物原料药及注射剂的研发、生产和销售。 | ||||||||||||||||||||||||
| Legal Representative | 甘忠如 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 邹蓉 | ||||||||||||||||||||||||
| Solicitors | 北京市中伦律师事务所 | ||||||||||||||||||||||||
| Auditors | 大华会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 010-80593699 | ||||||||||||||||||||||||
| Fax No | 010-80593678 | ||||||||||||||||||||||||
| Website | www.ganlee.com | ||||||||||||||||||||||||
| IR@ganlee.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 29/06/2020 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.600 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 0.200 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 18.080 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 27.447B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |